Filter
164
Text search:
Lu
C.,
Li
Z.
Featured
Recommendations
18
New Publications
14
Language
Document type
Studies & Reports
50
Guidelines
47
No document type
41
Fact sheets
12
Manuals
8
Training Material
3
Strategic & Response Plan
2
Infographics
1
Countries / Regions
Russia
9
Germany
7
Global
7
Middle East and North Africa
5
Peru
4
Brazil
4
Syria
3
Bangladesh
3
Yemen
3
Western and Central Europe
3
Spain
3
Congo, Democratic Republic of
2
Mozambique
2
Ecuador
2
Latin America and the Carribbean
2
Vietnam
2
Nigeria
1
Senegal
1
Mali
1
Guinea-Bissau
1
Philippines
1
India
1
Nepal
1
Pakistan
1
South Sudan
1
Afghanistan
1
Cambodia
1
Indonesia
1
South Africa
1
Sudan
1
Angola
1
Madagascar
1
Myanmar / Burma
1
Sri Lanka
1
West and Central Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Africa
1
Venezuela
1
Eastern Europe
1
Italy
1
Laos
1
Romania
1
France
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
53
Clinical Guidelines
14
Public Health
11
Women & Child Health
3
Pharmacy & Technologies
3
Capacity Building
1
Key Resources
1
Toolboxes
COVID-19
60
TB
15
Planetary Health
9
HIV
8
NCDs
7
Mental Health
6
Pharmacy
6
NTDs
4
Health Financing Toolbox
4
Refugee
3
AMR
3
Caregiver
3
Ebola
2
Rapid Response
2
Disability
1
Global Health Education
1
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de
...
El presente documento técnico tiene la finalidad de guiar el manejode cuidados intensivosde los pacientes conCOVID-19 con undoble objetivo: lograr el mejor tratamiento del paciente que contribuya a subuena evolución clínica; ygarantizar los niveles adecuados de prevención y control de la
...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent
...
Le HCSP a fondé ses recommandations sur les connaissances actuellement disponibles en particulier les publications scientifiques relatives au COVID-19 mais aussi de recommandations relatives à la prise en charge des pneumonies post grippales, et des pneumonies sévères en réanimation.
Cet avi
...
Scientific Brief, 30 June 2020
В настоящем документе представлен первоначальный обзор поступающей информации
(по состоянию на 2 июля 2020 г.) о взаимосвязи между COVID-19, НИЗ и факторами
риска НИЗ. Ре
...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de
...
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos y vacunas y orientando la respuesta sanitaria.
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch
...
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t
...
Consensual Recommendation for treatment of COVID-19 in older adults
Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
